The global warfarin market​ is projected to experience significant growth, with revenue expected to rise from its current valuation to USD 6.9 billion by 2033, achieving a steady compound annual growth rate (CAGR) of 5.1%​ from 2026 onward . This essential anticoagulant medication continues to play a critical role in treating and preventing thromboembolic disorders worldwide, creating a complex and dynamic buyer landscape across pharmaceutical sectors. Understanding the global warfarin procurement ecosystem​ is crucial for manufacturers, suppliers, and stakeholders seeking to capitalize on emerging opportunities in this specialized pharmaceutical market . 1. Market Overview and Therapeutic Applications Driving Demand The warfarin market​ has maintained consistent demand due to its proven…